Colostrum (Bovine) for Anti-Inflammatory

Research suggests that bovine colostrum and its bioactive components — including immunoglobulins, lactoferrin, growth factors, and exosomal microRNAs — may exert anti-inflammatory effects through several mechanisms, such as dampening NF-κB signaling, supporting gut barrier integrity, and modulating immune responses, with supporting evidence drawn primarily from cell-based laboratory studies, animal models, and narrative reviews rather than large-scale randomized clinical trials in humans. Studies indicate that whole bovine colostrum may outperform processed fractions in reducing inflammatory markers in laboratory settings, and colostrum-derived extracellular vesicles have shown promise in animal models of inflammation, though one study found that lactoferrin isolated from milk — rather than from whole colostrum — was actually the most effective form for inhibiting inflammation, suggesting that other components in colostrum may sometimes interfere with its active constituents. The evidence base is largely preclinical and review-level, with researchers consistently calling for more rigorous, standardized human clinical trials before broad conclusions can be drawn, and practical considerations such as milk protein allergies, potential concerns in immunocompromised individuals, and variability in colostrum composition and processing all represent important limitations to keep in mind. Overall, the research landscape is promising but preliminary, and the anti-inflammatory potential of bovine colostrum in humans remains an area of active investigation rather than an established finding.